Products in Development

The NanOlogy therapeutic platform is embodied in patented submicron particles of pure drug designed for targeted delivery via direct injection, inhalation, instillation, or topical application.

NANO2019productsgroupingNuNebuwide
NanoPac®
(Sterile Submicron Particle Paclitaxel for Suspension)

Ovarian Cancer (intraperitoneal)
Prostate Cancer (intratumoral)
Pancreatic Cancer (intratumoral)
Pancreatic Mucinous Cysts (intracystic)

NanoDoce®
(Sterile Submicron Particle Docetaxel for Suspension)

Bladder Cancer (local)
Renal Cancer (intratumoral)

NanoPac®
(Submicron Particle Paclitaxel for Nebulized Inhalation)

Non-Small Cell Lung Cancer (inhalation)

SOR007 Topical
 (Submicron Particle Paclitaxel Suspended in Anhydrous Base)

Cutaneous Metastases
Actinic Keratosis